The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England
Open accessAbstract
BACKGROUND: It is uncertain whether being overweight, but not obese, is associated with advanced chronic kidney disease (CKD) and how the size and shape of associations between body-mass index (BMI) and advanced CKD differs among different types of people. METHODS: We used Clinical Practice Research Datalink records (2000-2014) with linkage to English secondary care and mortality data to identify a prospective cohort with at least one BMI measure. Cox models adjusted for age, sex, smoking and social deprivation and subgroup analyses by diabetes, hypertension and prior cardiovascular disease assessed relationships between BMI and CKD stages 4-5 and end-stage renal disease (ESRD). FINDINGS: 1,405,016 adults aged 20-79 with mean BMI 27.4kg/m2 (SD 5.6) were followed for 7.5 years. Compared to a BMI of 20 to <25kg/m2, higher BMI was associated with a progressively increased risk of CKD stages 4-5 (hazard ratio 1.34, 95% CI 1.30-1.38 for BMI 25 to <30kg/m2; 1.94, 1.87-2.01 for BMI 30 to <35kg/m2; and 3.10, 2.95-3.25 for BMI ≥35kg/m2). The association between BMI and ESRD was shallower and reversed at low BMI. Current smoking, prior diabetes, hypertension or cardiovascular disease all increased risk of CKD, but the relative strength and shape of BMI-CKD associations, which were generally log-linear above a BMI of 25kg/m2, were similar among those with and without these risk factors. There was direct evidence that being overweight was associated with increased risk of CKD stages 4-5 in these subgroups. Assuming causality, since 2000 an estimated 39% (36-42%) of advanced CKD in women and 26% (22-30%) in men aged 40-79 resulted from being overweight or obese. CONCLUSIONS: This study provides direct evidence that being overweight increases risk of advanced CKD, that being obese substantially increases such risk, and that this remains true for those with and without diabetes, hypertension or cardiovascular disease. Strategies to reduce weight among those who are overweight, as well as those who are obese may reduce CKD risk, with each unit reduction in BMI yielding similar relative reductions in risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Four large trials recruiting different types of patients with CKD have confirmed the safety of intensive LDL-C lowering with statins alone (atorvastatin, rosuvastatin, fluvastatin), or combining a moderate dose of simvastatin with ezetimibe.698,[701][702][703][704]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [698]
Experimental — accuracy not yet measuredIn the citing paper
“Statin-based therapy reduces the risk of major atherosclerotic events (i.e.coronary death, non-fatal MI, ischaemic stroke, and coronary revascularization) in patients with CKD, but does not meaningfully slow progression of CKD.248,[697][698][699]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [698]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Self-citationReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citationThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
Di Angelantonio, E., Bhupathiraju, S. N., Wormser, D., Gao, P., Kaptoge, S., de Gonzalez, A. B., Cairns, B. J., Huxley, R., Jackson, C. L., Joshy, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30175-1 · Cited by 2,821
Self-citationData Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667
Andrassy, K. M. (2013) · Kidney International · doi:10.1038/ki.2013.243 · Cited by 2,496
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
Kovesdy, C. P., Furth, S. L., Zoccali, C., & on behalf of the World Kidney Day Steering Committee (2017) · American Journal of Nephrology · doi:10.1159/000458467 · Cited by 2,217
Plasma aldosterone regulation in anephric man
Walker, W. G., & Cooke, C. R. (1973) · Kidney International · doi:10.1038/ki.1973.1 · Cited by 1,841
Levey, A. S., & Coresh, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60178-5 · Cited by 1,841
Self-citationBhaskaran, K., Douglas, I., Forbes, H., dos-Santos-Silva, I., Leon, D. A., & Smeeth, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60892-8 · Cited by 1,707
Rapsomaniki, E., Timmis, A., George, J., Pujades-Rodriguez, M., Shah, A. D., Denaxas, S., White, I. R., Caulfield, M. J., Deanfield, J. E., Smeeth, L., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60685-1 · Cited by 1,643
Fox, C. S., Matsushita, K., Woodward, M., Bilo, H. J., Chalmers, J., Heerspink, H. J. L., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61350-6 · Cited by 1,401
Self-citationBody Mass Index and Risk for End-Stage Renal Disease
Hsu, C.-Y., McCulloch, C. E., Iribarren, C., Darbinian, J., & Go, A. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00006 · Cited by 1,390
Obesity-related glomerulopathy: An emerging epidemic
Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D'Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,286
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Hemmelgarn, B. R. (2010) · JAMA · doi:10.1001/jama.2010.39 · Cited by 1,041
Lipotoxicity: when tissues overeat
Schaffer, J. E. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200306000-00008 · Cited by 896
Colchero, M. A., Popkin, B. M., Rivera, J. A., & Ng, S. W. (2016) · BMJ · doi:10.1136/bmj.h6704 · Cited by 822
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Glomerular hyperfiltration: definitions, mechanisms and clinical implications
Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B., & Schrier, R. W. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.19 · Cited by 673
Glomerular hemodynamics in severe obesity
Chagnac, A., Weinstein, T., Korzets, A., Ramadan, E., Hirsch, J., & Gafter, U. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f817 · Cited by 614
Body mass index and the risk of development of end-stage renal disease in a screened cohort
Iseki, K., Ikemiya, Y., Kinjo, K., Inoue, T., Iseki, C., & Takishita, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00582.x · Cited by 603
Chronic kidney disease management in the United Kingdom: NEOERICA project results
Stevens, P. E., O'Donoghue, D. J., de Lusignan, S., Van Vlymen, J., Klebe, B., Middleton, R., Hague, N., New, J., & Farmer, C. K. T. (2007) · Kidney International · doi:10.1038/sj.ki.5002273 · Cited by 434
Lifestyle Factors, Obesity and the Risk of Chronic Kidney Disease
Stengel, B., Tarver–Carr, M. E., Powe, N. R., Eberhardt, M. S., & Brancati, F. L. (2003) · Epidemiology · doi:10.1097/01.ede.0000071413.55296.c4 · Cited by 407
Hippisley-Cox, J., Coupland, C., Robson, J., Sheikh, A., & Brindle, P. (2009) · BMJ · doi:10.1136/bmj.b880 · Cited by 372
Estimating the financial cost of chronic kidney disease to the NHS in England
Kerr, M., Bray, B., Medcalf, J., O'Donoghue, D. J., & Matthews, B. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs269 · Cited by 362
Fatty Kidney, Hypertension, and Chronic Kidney Disease: The Framingham Heart Study
Foster, M. C., Hwang, S.-J., Porter, S. A., Massaro, J. M., Hoffmann, U., & Fox, C. S. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175315 · Cited by 356
Attributable and Unattributable Risks and Fractions and other Scenario Comparisons
Newson, R. B. (2013) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1301300402 · Cited by 329
Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease
Vivante, A., Golan, E., Tzur, D., Leiba, A., Tirosh, A., Skorecki, K., & Calderon-Margalit, R. (2012) · Archives of Internal Medicine · doi:10.1001/2013.jamainternmed.85 · Cited by 321
Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
Ruggenenti, P., Porrini, E. L., Gaspari, F., Motterlini, N., Cannata, A., Carrara, F., Cella, C., Ferrari, S., Stucchi, N., Parvanova, A., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2189 · Cited by 321
(2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70156-1 · Cited by 319
Montani, J.-P., Carroll, J. F., Dwyer, T. M., Antic, V, Yang, Z., & Dulloo, A. G. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802858 · Cited by 298
Improved estimates of floating absolute risk
Plummer, M. (2004) · Statistics in Medicine · doi:10.1002/sim.1485 · Cited by 265
Medical Costs of CKD in the Medicare Population
Honeycutt, A. A., Segel, J. E., Zhuo, X., Hoerger, T. J., Imai, K., & Williams, D. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040392 · Cited by 261
Association of age and BMI with kidney function and mortality: a cohort study
Lu, J. L., Molnar, M. Z., Naseer, A., Mikkelsen, M. K., Kalantar-Zadeh, K., & Kovesdy, C. P. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00128-x · Cited by 223
Holmes, M. V., Lange, L. A., Palmer, T., Lanktree, M. B., North, K. E., Almoguera, B., Buxbaum, S., Chandrupatla, H. R., Elbers, C. C., Guo, Y., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.12.014 · Cited by 216
The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis
Fall, T., Hägg, S., Mägi, R., Ploner, A., Fischer, K., Horikoshi, M., Sarin, A.-P., Thorleifsson, G., Ladenvall, C., Kals, M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001474 · Cited by 203
Podocyte Lesions in Patients With Obesity-Related Glomerulopathy
Chen, H.-M., Liu, Z.-H., Zeng, C.-H., Li, S.-J., Wang, Q.-W., & Li, L.-S. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.07.025 · Cited by 192
Smith, D. H., Gullion, C. M., Nichols, G., Keith, D. S., & Brown, J. B. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000125670.64996.bb · Cited by 187
Bhaskaran, K., Forbes, H. J., Douglas, I., Leon, D. A., & Smeeth, L. L. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003389 · Cited by 162
Melsom, T., Schei, J., Stefansson, V. T. N., Solbu, M. D., Jenssen, T. G., Mathisen, U. D., Wilsgaard, T., & Eriksen, B. O. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.10.025 · Cited by 109
Obesity-Related Glomerulopathy in China: A Case Series of 90 Patients
Chen, H., Li, S., Chen, H., Wang, Q., Leishi, L., & Liu, Z.-H. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.303 · Cited by 106
Hyperglycemia and mechanical stress: Targeting the renal podocyte
Lewko, B., & Stępiński, J. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21856 · Cited by 104
Accuracy of GFR estimation in obese patients.
Lemoine, S., Guebre-Egziabher, F., Sens, F., Nguyen-Tu, M.-S., Juillard, L., Dubourg, L., & Hadj-Aissa, A. (2014) · American Society of Nephrology. Clinical Journal · doi:10.2215/cjn.03610413 · Cited by 103
Early histological changes in the kidney of people with morbid obesity
Goumenos, D. S., Kawar, B., Nahas, M. E., Conti, S., Wagner, B. E., Spyropoulos, C., Vlachojannis, J. G., Benigni, A., & Kalfarentzos, F. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp329 · Cited by 82
Obesity-related glomerulopathy and the nephron complement
Tsuboi, N., Utsunomiya, Y., & Hosoya, T. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft258 · Cited by 46
Obesity and kidney disease: Beyond the hyperfiltration
Mascali, A., Franzese, O., Nisticò, S. P., Campia, U., Lauro, D., Cardillo, C., Daniele, N. D., & Tesauro, M. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016643550 · Cited by 33
Quinn, M. P., Rainey, A., Cairns, K. J., Marshall, A. H., Savage, G. A., Kee, F., Maxwell, A. P., Reaney, E., & Fogarty, D. G. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm599 · Cited by 21
Impact of morbid obesity on the kidney function of patients with type 2 diabetes
Belhatem, N., Mohammedi, K., Rouzet, F., Matallah, N., Baloshi, A. A., Travert, F., Velho, G., Roussel, R., Guludec, D. L., Marre, M., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.028 · Cited by 15
Research works printed but not linked: 1
- Moody A. Health Survey for England 2013: Volume 1 Chapter 10: Adult anthropometric measures, overweight and obesity.
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citationKalantar-Zadeh, K., Jafar, T. H., Nitsch, D., Neuen, B. L., & Perkovic, V. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00519-5 · Cited by 1,461
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citationChronic kidney disease and the global NCDs agenda
Neuen, B. L., Chadban, S. J., Demaio, A. R., Johnson, D. W., & Perkovic, V. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2017-000380 · Cited by 246
“As highlighted by World Kidney Day, obesity is a significant marker of risk for CKD, independent of hypertension and diabetes, and therefore represents another important target for CKD screening and early detection.(7) There is evidence that weight reduction in CKD reduces proteinuria and blood pressure and may slow d…”
BackgroundChang, A. R., Grams, M. E., Ballew, S. H., Bilo, H., Correa, A., Evans, M., Gutierrez, O. M., Hosseinpanah, F., Iseki, K., Kenealy, T., et al. (2019) · BMJ · doi:10.1136/bmj.k5301 · Cited by 233
Self-citation
Metadata
- Authors
- Herrington, W. G., Smith, M., Bankhead, C., Matsushita, K., Stevens, S., Holt, T., Hobbs, F. D. R., Coresh, J., & Woodward, M.
- Affiliations
- Churchill Hospital (GB)
- University of Oxford (GB)
- Johns Hopkins University (US)
- The University of Sydney (AU)
- Corresponding author
- Herrington, William G.
- Bankhead, Clare
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-03-08
- Volume
- 12
- Issue
- 3
- Pages
- e0173515
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5342319
- OpenAlex
- W2593429896
- Cited by
- 141
- References
- 63
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 23 · 2023: 16 · 2022: 12 · 2021: 17 · 2020: 23 · 2019: 7 · 2018: 9 · 2017: 2
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute for Health Research
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- body mass index, overweight, obesity, advanced chronic kidney disease, end-stage renal disease, weight loss, diabetes mellitus, hypertension, cardiovascular disease, smoking, sex differences, primary care cohort, Clinical Practice Research Datalink, kidney disease prevention, England, United Kingdom, social deprivation, cardiovascular risk factors
- MeSH terms
- Adult, Aged, England, Female, Humans, Male, Middle Aged, Obesity, Population Surveillance, Primary Health Care, Prospective Studies, Risk Factors, Comorbidity, Body Mass Index, Proportional Hazards Models, Risk Assessment, Overweight, Renal Insufficiency, Chronic, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.